Maternal Dietary Diversity Lowers Childhood Eczema Risk: Study

A new study published in the journal of Pediatric Allergy and Immunology revealed that greater dietary diversity during pregnancy was associated with a reduced risk of atopic dermatitis in early childhood. The findings of the study emphasize on the potential protective role of maternal nutrition.

The research followed 677 mother-infant pairs from pregnancy through the children’s first 3 years, examined how maternal dietary diversity influenced the development of atopic dermatitis, while also considering the role of the infant gut microbiome.

To assess diet quality, this study used the Minimum Dietary Diversity for Women (MDD-W) guideline developed by the Food and Agriculture Organization. This measure evaluates whether a mother consumes foods from a broad range of groups, including whole grains, proteins, dairy, fruits, and vegetables, during pregnancy. Infant gut microbiota was analyzed at 2 months postpartum, and the incidence of atopic dermatitis in the children was monitored up to age three.

Also, while maternal diet did not appear to influence the overall diversity of the infant gut microbiome (alpha and beta diversity) it did alter its composition. The study highlighted 2 bacterial genera namely Rothia and Parabacteroides, both of which were linked to reduced risk of atopic dermatitis when present in greater abundance.

The analysis also revealed a connection between maternal nutrient intake and microbiome composition. Vitamin A-rich fruits and vegetables, like carrots, sweet potatoes, and leafy greens, were linked to higher levels of the Parabacteroides genus, which suggests a potential pathway through which maternal diet supports infant immune resilience.

The mothers with the lowest dietary diversity had the highest rates of children developing the condition, whereas the individuals with the broadest food group intake showed markedly lower incidence. Additional data demonstrated that while microbiome diversity metrics (alpha and beta diversity) were not significantly different across groups, shifts in microbial composition were consistently observed in association with maternal diet quality.

Overall, the findings suggest that maternal dietary diversity during pregnancy may help protect against atopic dermatitis in children, possibly through modulation of the infant gut microbiome. However, further studies are required to confirm these findings and clarify the biological mechanisms involved.

Source:

Huynh, L. B. P., Fan, H.-Y., Huang, S.-Y., Nam, N. N., Nguyen, T. T., & Chen, Y.-C. (2025). Influence of maternal dietary diversity during pregnancy on infant atopic dermatitis: Exploring the microbiome link in a Taiwanese birth cohort. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology, 36(9),. https://doi.org/10.1111/pai.70200

Powered by WPeMatico

Rheumatoid Arthritis Patients Face Higher Risk of Kidney Stones: Study

Kidney stone disease remains a growing health concern worldwide, with metabolic, inflammatory, and lifestyle factors all contributing to risk. New research now suggests that individuals with rheumatoid arthritis (RA) may be particularly vulnerable.

In a large population-based study involving nearly 20,000 participants, researchers found that patients with RA experienced more than double the incidence of kidney stones compared to those without the condition. The association persisted even after adjusting for common risk factors such as age, sex, and comorbidities, highlighting a potential link between systemic inflammation and stone formation. Rheumatoid arthritis is a chronic autoimmune disease characterized by persistent joint inflammation and systemic immune dysregulation. Researchers propose several possible mechanisms that could explain the elevated risk of nephrolithiasis in RA patients. Chronic inflammation may alter calcium and uric acid metabolism, leading to increased urinary excretion and crystal deposition. Additionally, medications frequently used in RA management—such as corticosteroids and diuretics—may contribute to stone formation by influencing fluid balance and renal handling of minerals. Reduced physical activity and dietary modifications in RA patients could also indirectly affect risk. Importantly, the study’s design limited causal inference. While the findings underscore a significant association, they do not establish that RA directly causes kidney stones. Instead, the results suggest that RA may act as a clinical marker of increased susceptibility, requiring further mechanistic and longitudinal research to clarify causality. Clinically, these findings carry important implications. Physicians caring for RA patients should be aware of the heightened risk of nephrolithiasis and consider proactive monitoring, especially in individuals with additional metabolic risk factors. Lifestyle strategies such as hydration, balanced diets, and metabolic screening may help mitigate risks. Overall, the study highlights the broader systemic burden of RA beyond joint disease, adding kidney stones to the list of potential comorbidities requiring integrated care.

Keywords
rheumatoid arthritis, kidney stones, nephrolithiasis, autoimmune disease, inflammation, metabolic risk, comorbidity, uric acid, corticosteroids, cohort study

Reference:

Yue, G., Yan, Y., Zeng, X. et al. Association between rheumatoid arthritis and kidney stones: A cross-sectional study of NHANES 2007–2020. Arthritis Res Ther 27, 141 (2025). https://doi.org/10.1186/s13075-025-03604-w

Powered by WPeMatico

Biparametric MRI Effective as Multiparametric MRI in Detecting Prostate Cancer: Study

A recent study published in the Journal of the American Medical Association found biparametric MRI to performs just as well as the current gold-standard multiparametric MRI in detecting clinically significant prostate cancer. The findings could reshape global diagnostic practices, particularly in health systems struggling with capacity and cost constraints.

Multiparametric MRI has long been considered the standard for diagnosing prostate cancer, combining T2-weighted, diffusion-weighted, and dynamic contrast–enhanced (DCE) sequences. While highly effective, this approach is resource-intensive and relies on gadolinium-based contrast, raising both logistical and financial barriers. Biparametric MRI excludes the DCE sequence and offers a faster and less costly alternative. 

From April 2022 to September 2023, this trial enrolled 555 biopsy-naive men with elevated prostate-specific antigen (PSA) levels or abnormal digital rectal exams. Conducted across 22 centers in 12 countries, the study analyzed data from 490 participants after exclusions. The men, with a median age of 65 years and median PSA of 5.6 ng/mL, underwent both biparametric and multiparametric MRI. The radiologists first reported on biparametric scans without access to DCE data, then assessed the full multiparametric images.

If either imaging modality suggested clinically significant cancer, patients received targeted biopsies, with or without additional systematic sampling. The trial was designed to test whether biparametric MRI was “noninferior” to multiparametric MRI, with a 5% margin set for acceptable difference.

The study found biparametric MRI help identify cancer in 29.2% of men (143 out of 490) while multiparametric MRI detected it in 29.6% (145 out of 490). The difference was a mere −0.4 percentage points, statistically insignificant and well within the noninferiority margin.

Detection rates of clinically insignificant cancers were also nearly identical. Biparametric MRI flagged 9.2% of men, when compared with 9.6% for multiparametric scans. Also, central quality control showed that 99% of all scans were diagnostically adequate, highlighting the reliability of the abbreviated technique.

With approximately 4 million prostate MRIs performed worldwide each year, the shift to biparametric imaging could free up scanner time, shorten waiting lists, and reduce costs without compromising care. Overall, the findings suggest that, provided imaging quality is maintained, biparametric MRI has the potential to become the new global standard in prostate cancer diagnosis. 

Reference:

Ng, A. B. C. D., Asif, A., Agarwal, R., Panebianco, V., Girometti, R., Ghai, S., Gómez-Gómez, E., Budäus, L., Barrett, T., Radtke, J. P., Kesch, C., De Cobelli, F., Pham, T., Taneja, S. S., Hu, J. C., Tewari, A., Rodríguez Cabello, M. Á., Dias, A. B., Mynderse, L. A., … PRIME Study Group Collaborators. (2025). Biparametric vs multiparametric MRI for prostate cancer diagnosis: The PRIME diagnostic clinical trial. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.2025.13722

Powered by WPeMatico

Low Hb Levels may Increase Risk of Diabetic Retinopathy in Adults with Type 2 Diabetes: Study

A recent study published in the journal of Eye revealed that low hemoglobin levels may significantly raise the risk of developing diabetic retinopathy (DR). The findings highlight hemoglobin as an overlooked but potentially modifiable risk factor in managing type 2 diabetes.

The research used the TriNetX network from 2010 to 2022 and analysed data from over 57,000 adults aged 45 years and older with type 2 diabetes. The participants were divided into a low hemoglobin (LHB) group, defined as 8–12 g/dL, and a control group with levels ≥12 g/dL. To ensure balanced comparisons, propensity score matching was employed to account for confounding factors such as age, sex, and comorbidities.

The study tracked the onset of new DR cases within a 6 to 36 month follow-up period. The results showed a striking increase in risk among the individuals with lower hemoglobin. Specifically, the LHB group underwent a 33% higher risk of developing overall DR when compared with controls. When broken down into subtypes, the risk of proliferative DR was nearly doubled (HR: 1.95). Non-proliferative DR, a less severe but still concerning stage, also showed a modest yet significant risk increase of 19% (HR: 1.19).

The study found that even mild reductions in hemoglobin (10–12 g/dL) were enough to elevate DR risk, suggesting that attention should not be limited to only severe anemia cases. Subgroup analysis shed further light on this relationship. The association between low hemoglobin and DR was stronger in patients without hypertension (HR: 1.58 vs. 1.21 in hypertensive individuals).

It also remained consistent regardless of blood sugar control, as measured by HbA1c, highlighting hemoglobin as an independent factor. Also, men appeared more vulnerable than women, showing a more pronounced association.

Overall, these findings have important implications for clinical practice. While blood glucose and blood pressure management remain cornerstones of diabetes care, the study suggests that routine monitoring and optimisation of hemoglobin levels could play a critical role in preventing sight-threatening complications.

Source:

Hung, K.-C., Chang, L.-C., Chang, Y.-J., Hsu, C.-W., Yew, M., Wu, J.-Y., & Chen, I.-W. (2025). Association between haemoglobin levels and the risk of diabetic retinopathy in adults with type 2 diabetes: a retrospective cohort study using the TriNetX network. Eye, 1–8. https://doi.org/10.1038/s41433-025-03982-0

Powered by WPeMatico

Wearable devices could revolutionize pregnancy monitoring and detect abnormalities: Study

A simple fitness tracker might hold the key to revolutionizing maternal healthcare. Scientists at Scripps Research have found preliminary evidence suggesting that common wearable devices such as the Apple Watch, Garmin and Fitbit could remotely monitor pregnancy-related health changes by tracking physiological patterns-like heart rate-that correlate with hormonal fluctuations.

“Wearable devices offer a unique opportunity to develop innovative solutions that address the high number of adverse pregnancy outcomes in the U.S.,” says co-senior author Giorgio Quer, the director of artificial intelligence and assistant professor of Digital Medicine at Scripps Research. “Our results show that signals collected via wearable sensors follow the expected changes in hormone levels and can detect unique patterns specific to live birth pregnancies, potentially allowing the monitoring of maternal health throughout the pregnancy and postpartum.”

The findings, released in the Lancet eBioMedicine on August 28, 2025, come at a crucial time for maternal health in the U.S. More than 2 million women of childbearing age live in maternal care deserts, or areas with severely limited access to obstetric care. Pregnancy complications, including miscarriage and preterm birth, continue to pose significant risks to maternal and child health, demanding more effective ways to monitor and address these outcomes.

Aligning heart rates and hormones

To gather the data, the team used PowerMom , a bilingual digital research platform, which allowed participants to voluntarily report real-world data from their personal wearable devices after providing informed consent—capturing valuable information beyond the traditional prenatal clinic visits. The researchers enrolled over 5,600 participants who explicitly agreed to share their data and selected 108 individuals who had consented to provide data from three months before their pregnancy through six months after delivery. Using sophisticated statistical methods to identify population-level patterns, the team could account for individual differences and device variations.

From this data, the scientists were able to identify physiological patterns that aligned with the fluctuation of key pregnancy hormones such as estrogen, progesterone and human chorionic gonadotropin (hCG). The fluctuations of these hormones are critical to healthy pregnancy outcomes and provide insight into the pregnancy’s progression.

The heart rate data was particularly compelling. During early pregnancy, researchers found that the individual’s heart rate initially decreased around weeks five to nine, then steadily increased until about eight or nine weeks before delivery, reaching peaks up to 9.4 beats per minute above pre-pregnancy levels. After birth, the heart rate dropped below baseline levels before stabilizing around six months postpartum. The researchers also tracked sleep and activity patterns throughout pregnancy.

To validate this correlation, the team compared wearable sensor patterns with published hormone-level data from previous pregnancy studies, creating detailed models that predicted heart rate changes based on expected hormonal fluctuations throughout pregnancy. While these findings are still early, they demonstrate that wearables could potentially enhance prenatal care, particularly for women living in maternal care deserts.

“Hormones play a key role in pregnancy outcomes,” explains co-senior author Tolúwalàṣẹ Àjàyí, co-senior author and principal investigator of PowerMom. “Discovering the association between heart rate and hormone changes could unlock new ways to predict the beginning of pregnancy or identify signs of adverse outcomes such as gestational diabetes or preeclampsia.”

In an exploratory analysis of a small number of cases, pregnancies ending in adverse outcomes like miscarriage or stillbirth showed different heart rate patterns compared to healthy pregnancies, though more research with larger sample sizes is needed to validate these observations.

The future of health monitoring

This research represents a significant step toward making pregnancy monitoring more accessible through technology that many individuals already own and use. By transforming consumer devices into medical monitoring tools, the approach could help bridge healthcare gaps and provide continuous oversight for high-risk pregnancies.

The digital approach builds on growing evidence that wearable devices can detect meaningful health changes much earlier.Previous work has shown their role in identifying COVID-19 infections and other health conditions through physiological pattern recognition.

The researchers plan to expand their analysis with a focus on understanding how patterns may vary across different demographic groups, geographic regions and socioeconomic backgrounds. They hope to eventually develop models that could identify birthing individuals who might benefit from additional monitoring or support.

“We want to understand if these patterns are consistent across subgroups based on age and access to care,” says first author and UC San Diego graduate student, Giulia Milan, who conducted this study in collaboration with Scripps Research. “Our goal is to determine whether this approach could eventually contribute to more personalized pregnancy care.”

Future studies will need to investigate whether physiological changes captured by wearables could potentially support clinical decision-making and patient care. The team also plans to collect both wearable data and blood samples from the same participants to directly validate the hormone-heart rate associations observed in this preliminary analysis.

Powered by WPeMatico

AI analysis of colonoscopy improves assessment of Crohn’s disease

In a new study, artificial intelligence matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients.

The results, published in Clinical Gastroenterology and Hepatology, show a computer vision model identified mucosal ulceration as accurately as physician reviewing videos, while also being strongly correlated with the most common endoscopic scoring system.

“A clinician has a gestalt of whether someone’s Crohn’s is mild or severe, if it’s improving or worsening,” said Ryan W. Stidham, M.D., M.S., associate professor of internal medicine at the University of Michigan Medical School and senior author of the paper.

“But the manual tools to quantify that expert opinion with objectivity and reproducibly are poor. AI image analysis can provide better solutions for more precise measurements and descriptions of what we are seeing on the screen during colonoscopy.”

In the study, two gastroenterologists annotated ulcer areas in 4,487 still images from endoscopic videos. The computer vision AI model reviewed the same images, from previous clinical trials.

The AI model’s results had a higher overall DICE similarity score with ground truth (.591) than when comparing the agreement between two gastroenterologists (.462).

Computer vision assessments of the colonoscopy videos were also strongly correlated with Simple Endoscopic Score for Crohn’s Disease (SES-CD) values. SES-CD is a metric that attempts to manually quantify various characteristics of a patient’s ulceration.

While study authors note the importance of SES-CD for Crohn’s disease research and assessing the effectiveness of treatment, they also highlight its limitations, including variability among observers and inability to capture certain ulcer features.

Researchers hope that AI-powered metrics will not only improve consistency between providers but more importantly may offer more quantitative detail to describe disease.

“It can be hard to justify decisions, particularly if you’re talking about expensive drugs or riskier therapies,” Stidham said.

“One of the reasons for this research is to one day provide more objective evidence for an experienced clinician’s impression.”

Researchers identify several other potential advantages to more consistent endoscopy metrics. In areas without IBD specialists AI endoscopy interpretation may be used to guide treatment change based on expert decision making. For more experienced providers, the information can help them understand their own decision-making process.

They also highlight possible implications for education and drug development.

“This paper is really the first step, and I hope that it gets the entire field thinking of better ways to quantify IBD that more completely describe an individual patient,” Stidham said.

“It’s very early, but computer vision tools like this may provide an important component for the future of automated care, where AI and experts work together in treating patients.” 

Reference:

Cai, Lingrui et al., Artificial Intelligence for Quantifying Endoscopic Mucosal Ulceration in Crohn’s Disease, Clinical Gastroenterology and Hepatology, DOI:10.1016/j.cgh.2025.05.026 

Powered by WPeMatico

Pregnancy Hypertension Linked to Lower Childhood IQ, Large Meta-Analysis Finds

Australia: Children born to mothers with hypertensive disorders of pregnancy face a heightened risk of cognitive and developmental challenges, according to a large systematic review and meta-analysis published in PLOS Medicine. The research shows that while links to autism and global developmental delay diminish when factors such as birthweight and gestational age are considered, a measurable reduction in average IQ persists, underscoring the importance of early monitoring and support for these children.

The study, led by Roxanne M. Hastie from the University of Melbourne’s Perinatal Epidemiology Group and Mercy Perinatal at Mercy Hospital for Women in Victoria, Australia, brings together data from 121 studies encompassing nearly 30 million children worldwide. Investigators pooled evidence from cohort, case–control, and cross-sectional studies to explore how maternal hypertensive disorders—including preeclampsia and gestational hypertension—might influence offspring neurodevelopment, intelligence, and educational outcomes.
The following were the key findings:
  • Children exposed in utero to hypertensive pregnancy disorders had a 65% higher odds of developing autism spectrum disorder.
  • The odds of attention-deficit/hyperactivity disorder (ADHD) increased by 27% in these children.
  • The likelihood of intellectual disability and global developmental delay each rose by 77%.
  • Mean intelligence scores were lower by an average of 2.2 points compared with children from unaffected pregnancies.
  • After adjusting for gestational age and birthweight, the elevated risks for autism and global developmental delay were no longer statistically significant.
  • The reduction in IQ remained evident after adjusting for birthweight but weakened when gestational age was considered, indicating overlapping and complex pathways.
The review team emphasized that despite these nuances, the findings point to a vulnerable population of children who could benefit from proactive developmental assessments and early interventions. Early identification of cognitive or behavioral difficulties can enable timely educational and therapeutic support, potentially improving long-term outcomes.
Researchers also noted limitations within the available evidence. Many of the included studies lacked comprehensive adjustment for confounding factors, and there was considerable variation in study design and quality. Nonetheless, sensitivity analyses excluding high-risk studies did not change the overall conclusions.
While the exact biological mechanisms remain unclear, hypertensive disorders of pregnancy are known to affect placental function and fetal growth, which may influence brain development. Dr. Hastie and colleagues call for further research to disentangle the roles of gestational age, birthweight, and other mediating factors.
The large-scale analysis highlights that children born following hypertensive pregnancies, even those without obvious complications at birth, may carry a subtle but significant risk of lower cognitive performance. The authors advocate early developmental surveillance and targeted support as a prudent strategy to help these children achieve their full potential.
Reference:
Atkinson JA, Gordon HG, Tong S, Walker SP, Mehdipour P, Lindquist AC, et al. (2025) Hypertensive disorders of pregnancy and childhood neurodevelopment: A systematic review and meta-analysis. PLoS Med 22(9): e1004558. https://doi.org/10.1371/journal.pmed.1004558

Powered by WPeMatico

New bioactive dressing promises faster diabetic wound healing, reveals research

Chronic diabetic wounds, including diabetic foot ulcers, are a significant burden for patients, as impaired blood vessel growth hinders the healing process. A recent breakthrough offers hope by combining small extracellular vesicles (sEVs) loaded with miR-221-3p and a GelMA hydrogel to target thrombospondin-1 (TSP-1), a protein that suppresses angiogenesis. This new bioactive wound dressing not only accelerates healing but also promotes blood vessel formation, offering a promising new approach to treating one of the most challenging complications of diabetes.

Diabetic wounds, particularly foot ulcers, are notorious for their slow and often incomplete healing due to reduced blood flow and endothelial cell dysfunction. One of the major contributors to this issue is thrombospondin-1 (TSP-1), which inhibits the growth of new blood vessels, a process crucial for tissue repair. Despite various existing treatments, the challenge of addressing this barrier to healing remains unmet. With the global rise in diabetes cases, new treatments targeting the underlying causes of delayed wound healing have become a critical area of research. In light of these ongoing challenges, this study explores a new approach to stimulate angiogenesis and speed up the healing process.

In a new study (DOI: 10.1093/burnst/tkaf036) published in Burns & Trauma, a team of researchers from leading Chinese institutions has unveiled a novel therapeutic solution for diabetic wound healing. The study introduces an innovative wound dressing that combines miR-221OE-sEVs—engineered extracellular vesicles that target and reduce TSP-1 levels—with a GelMA hydrogel to create a sustained-release system. This cutting-edge approach has shown to significantly enhance wound healing and blood vessel formation in diabetic mice, offering hope for more effective treatments in the future.

In their study, the researchers discovered that high glucose conditions commonly found in diabetic wounds lead to increased levels of TSP-1 in endothelial cells, impairing their ability to proliferate and migrate—key processes for angiogenesis. By utilizing miR-221-3p, a microRNA that targets and downregulates TSP-1 expression, they restored endothelial cell function. The engineered miR-221OE-sEVs were encapsulated within a GelMA hydrogel, ensuring a controlled release at the wound site, mimicking the extracellular matrix. In animal trials, this composite dressing dramatically accelerated wound healing, with a notable increase in vascularization and a 90% wound closure rate within just 12 days, compared to slower healing in control groups.

Dr. Chuan’an Shen, a key researcher in the study, shared his excitement about the potential impact of this innovation: “Our results demonstrate the power of combining advanced tissue engineering with molecular biology. By targeting TSP-1 with miR-221OE-sEVs encapsulated in GelMA, we’ve not only improved endothelial cell function but also ensured a sustained and localized therapeutic effect. This breakthrough could revolutionize how we approach diabetic wound care, with the potential to improve patients’ quality of life significantly.”

The success of this engineered hydrogel in diabetic wound healing opens up several exciting possibilities. Beyond diabetic foot ulcers, the technology could be adapted for use in treating other chronic wounds, such as those caused by vascular diseases, or even in regenerating tissues like bone and cartilage. As further research and clinical trials progress, the promise of combining miRNA-based therapies with biocompatible hydrogels could become a cornerstone in regenerative medicine, offering patients more efficient and lasting wound healing solutions.

Reference:

Yan Cong, Sheng Meng, Xiaoye Xie, Yiqi Chen, Yucong Li, Yingqian Zhou, Wandi Li, Lipeng Zhang, Guoqing Yang, Qian Wei, Chuan’an Shen, Engineered sEVs encapsulated in GelMA facilitated diabetic wound healing by promoting angiogenesis via targeting thrombospondin-1, Burns & Trauma, 2025;, tkaf036, https://doi.org/10.1093/burnst/tkaf036

Powered by WPeMatico

Researchers find brain region that fuels compulsive drinking

What compels someone to keep engaging in alcohol use, even if it damages their health, relationships and wellbeing? A new study from Scripps Research offers an important clue: a small midline brain region plays a key role in how animals learn to continue drinking to avoid the stress and misery of withdrawal.

In a new study, published in Biological Psychiatry: Global Open Science on August 5, 2025, the Scripps Research team zeroed in on a set of brain cells in the paraventricular nucleus of the thalamus (PVT) in rats. They found that this region becomes more active, driving strong relapse behavior, when rats learn to associate environmental stimuli with the easing of withdrawal symptoms by alcohol. By illuminating this brain pathway, the research sheds light on one of the most stubborn features of addiction-drinking not for pleasure, but to escape pain-and could eventually lead to new treatments for substance use disorders (SUDs) as well as other maladaptive behaviors including anxiety.

“What makes addiction so hard to break is that people aren’t simply chasing a high,” says Friedbert Weiss, professor of neuroscience at Scripps Research and senior author of the study. “They’re also trying to get rid of powerful negative states, like the stress and anxiety of withdrawal. This work shows us which brain systems are responsible for locking in that kind of learning, and why it can make relapse so persistent.”

“This brain region just lit up in every rat that had gone through withdrawal-related learning,” says co-senior author Hermina Nedelescu of Scripps Research. “It shows us which circuits are recruited when the brain links alcohol with relief from stress0and that could be a game-changer in how we think about relapse.”

From behavior to brain maps

An estimated 14.5 million people in the United States have alcohol use disorder, which encompasses a range of unhealthy drinking behaviors. Like other drug addictions, alcohol addiction is characterized by cycles of withdrawal, abstinence and relapse.

In 2022, Weiss and Nedelescu used rats to study the types of learning that happen in the brain throughout this cycle. When rats initially begin drinking, they learn to associate pleasure with alcohol and seek more. However, that conditioning becomes far stronger during multiple cycles of withdrawal and relapse. After learning that alcohol eased the unpleasant feelings of withdrawal—what scientists call negative reinforcement or a relief of ‘negative hedonic state’—the animals sought out more alcohol and would remain persistent even when uncomfortable.

“When rats learn to associate environmental stimuli or contexts with the experience of relief, they end up with an incredibly powerful urge to seek alcohol in the presence of that stimuli –even if conditions are introduced that require great effort to engage in alcohol seeking,” says Weiss. “That is, these rats seek alcohol even if that behavior is punished.”

In the new work, the team wanted to pin down exactly what networks of cells in the brain were responsible for learning to associate environmental cues with the relief of this negative hedonic state.

The researchers used advanced imaging tools to scan entire rat brains, cell by cell, and pinpoint areas that became more active in response to alcohol-related cues. They compared four groups of rats: those that had gone through withdrawal and learned that alcohol relieves a negative hedonic state, and three different control groups that had not.

While several brain areas showed increased activity in the withdrawal-learned rats, one stood out: the PVT, which is known for its role in stress and anxiety.

“In retrospect, this makes a lot of sense,” says Nedelescu. “The unpleasant effects of alcohol withdrawal are strongly associated with stress, and alcohol is providing relief from the agony of that stressful state.”

The researchers hypothesize that this negative hedonic state, and the activation of the PVT in the brain as a response, is critical for how the brain learns and perpetuates addiction.

A better understanding of addiction

The implications of the new study extend well beyond alcohol, the researchers say. Environmental stimuli conditioned to negative reinforcement—the drive to act in order to escape pain or stress-is a universal feature of the brain, and can drive human behavior beyond substance use disorders such as anxiety disorders, fear-conditioning and traumatic avoidance learning.

“This work has potential applications not only for alcohol addiction, but also other disorders where people get trapped in harmful cycles,” says Nedelescu.

Reference:

Hermina Nedelescu, Elias Meamari, Nami Rajaei, Alexus Grey, Ryan Bullard, Nathan O’Connor, Nobuyoshi Suto, Friedbert Weiss, Recruitment of Neuronal Populations in the Paraventricular Thalamus of Alcohol Seeking Rats with Withdrawal-related Learning Experience, Biological Psychiatry Global Open Science, https://doi.org/10.1016/j.bpsgos.2025.100578.

Powered by WPeMatico

Nanoparticles Could Revolutionize Endodontics — Promise and Practical Hurdles: Study

Belgium: Researchers have found in a new study that nanoparticles offer significant potential in endodontics by enhancing antibacterial and biocompatible properties compared to conventional materials. However, concerns about long-term biocompatibility, manufacturing scalability, and clinical integration remain; the review calls for focused translational research to safely and practically integrate these laboratory advances into everyday dental practice.

The scoping review, published in Discover Nano by Una Ivković and colleagues from the OMFS-IMPATH Research Group, Department of Imaging and Pathology, Faculty of Medicine, University of Leuven, Belgium, highlights the expanding role of multifunctional nanoparticles in endodontics. These nanoscale materials are being investigated for their potential to regenerate the dentin–pulp complex, enhance the mechanical and biological performance of dental materials, and act as carriers for targeted therapeutic delivery.

Following PRISMA-Scoping Review guidelines, the team conducted an extensive literature search across Web of Science, PubMed, and Scopus. Of 490 initially identified articles, 70 met the inclusion criteria after full-text review. Data from both in vitro and in vivo studies were summarized, revealing that inorganic nanomaterials dominated the research landscape, featuring in 77% of studies, while organic nanomaterials accounted for 23%.

The study revealed the following findings:

  • Organic nanomaterials such as chitosan (29% of carrier applications) and extracellular vesicles (22% of therapeutic uses) showed considerable potential despite being less frequently studied.
  • Among inorganic nanomaterials, bioactive glass was a leading candidate, appearing in 31% of enhancer-related studies, 26% of therapeutic studies, and 13% of carrier-focused research.
  • Most applications (69% of studies) were directed toward pulp capping or root canal filling, reflecting the need for advanced materials in these procedures.
  • Research models included 75% in vitro experiments using relevant cell lines and 25% animal model studies, with 18% of the latter also incorporating parallel in vitro testing.
  • Nanoparticles consistently enhanced antibacterial activity and bioactivity compared with conventional endodontic materials, offering solutions to issues like reinfection and poor biological integration.

However, translating these benefits to clinical settings poses significant challenges. Current evidence is heavily based on controlled laboratory conditions that may not fully replicate the complexity of the oral environment. The authors highlight the need for more physiologically relevant models, including 3D culture systems, microfluidic tissue-on-chips, and organ-on-chips, to bridge this gap.

Future research priorities include optimizing nanoparticle formulations for specific therapeutic objectives, establishing standardized testing protocols to improve reproducibility, and expanding antibacterial evaluations to reflect the diverse microbial environment of the oral cavity. Additionally, robust clinical trials are essential to confirm real-world safety, effectiveness, and cost-efficiency.

The authors conclude that incorporating nanoparticles into endodontic practice could shift the field from a reliance on bio-inert materials to bioactive, regenerative solutions. By enabling tissue preservation, promoting healing, and facilitating targeted therapies, these innovative materials hold the potential to significantly enhance long-term outcomes for patients undergoing endodontic treatment.

Reference:

Ivković, U., Moreno-Rabié, C., Mignon, A. et al. Multifunctional nanoparticles in endodontics: applications, challenges, and future directions. Discover Nano 20, 130 (2025). https://doi.org/10.1186/s11671-025-04314-7

Powered by WPeMatico